Document is current
Any future updates will be listed below
-
Authors
Leinders, Sacha
Aarnoutse, Erik J.
Branco, Mariana P.
Freudenburg, Zac V.
Geukes, Simon H.
Schippers, Anouck
Verberne, Malinda S.W.
van den Boom, Max A.
van der Vijgh, Benny H.
Crone, Nathan E.
Denison, Timothy
Ramsey, Nick F.
Vansteensel, Mariska J.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (UH3NS114439)
European Research Council (ADV 320708)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (UGT7685)
National Institute on Deafness and Other Communication Disorders (U01DC016686)
- License Information
-
More Information
Article History
Received: 12 October 2025
Accepted: 10 March 2026
First Online: 18 March 2026
Declarations
:
: Timothy Denison is a shareholder in Amber Therapeutics, board member at ONWARD, advisory board member and consultant with Cortec Neuro, and consultant with Synchron. Nick F. Ramsey was consultant for the Wyss Center (Geneva). Mariska J. Vansteensel was consultant for GA Capital and former board member ofthe International BCI Society.
